Protalix BioTherapeutics (PLX) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 1,453.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,453.53% |
| Dec 31, 2025 | 92.74% |
| Sep 30, 2025 | -102.48% |
| Jun 30, 2025 | -143.33% |
| Mar 31, 2025 | 48.51% |
| Dec 31, 2024 | -4,379.53% |
| Sep 30, 2024 | 197.36% |
| Jun 30, 2024 | 18.92% |
| Mar 31, 2024 | -112.81% |
| Dec 31, 2023 | -106.90% |
| Sep 30, 2023 | -453.16% |
| Jun 30, 2023 | -162.18% |
| Mar 31, 2023 | 129.11% |
| Dec 31, 2022 | -86.77% |
| Sep 30, 2022 | 27.72% |
| Jun 30, 2022 | -95.27% |
| Mar 31, 2022 | 47.02% |
| Dec 31, 2021 | 393.10% |
| Sep 30, 2021 | -40.68% |
| Jun 30, 2021 | 2,913.43% |
| Mar 31, 2021 | 12.53% |
| Dec 31, 2020 | 26,079.31% |
| Sep 30, 2020 | 1,849.55% |
| Jun 30, 2020 | -182.11% |
| Mar 31, 2020 | -9,355.26% |
| Dec 31, 2019 | -65.48% |
| Sep 30, 2019 | -95.61% |
| Jun 30, 2019 | 20.17% |
| Mar 31, 2019 | -13.11% |
| Dec 31, 2018 | 347.06% |
| Sep 30, 2018 | -96.55% |
| Jun 30, 2018 | 82.65% |
| Mar 31, 2018 | -15.90% |
| Dec 31, 2017 | 85.95% |
| Sep 30, 2017 | -75.76% |
| Jun 30, 2017 | -87.43% |
| Mar 31, 2017 | 3.41% |
| Dec 31, 2016 | -100.61% |
| Sep 30, 2016 | 60.95% |
| Jun 30, 2016 | -47.58% |
| Mar 31, 2016 | -195.96% |
| Mar 31, 2015 | 73.24% |
| Mar 31, 2014 | 46.30% |
| Dec 31, 2013 | 27.93% |
| Sep 30, 2013 | 48.84% |
| Jun 30, 2013 | -202.51% |
| Mar 31, 2013 | 19.13% |
| Dec 31, 2012 | 49.67% |
| Sep 30, 2012 | 20.33% |
| Jun 30, 2012 | 83.44% |
| Mar 31, 2012 | 67.85% |
| Dec 31, 2011 | 30.51% |
| Sep 30, 2011 | 25.72% |